Pub Date : 2023-03-01DOI: 10.1097/JDN.0000000000000725
Manushi Aggarwal, V. Sandhu
ABSTRACT Scleroderma is a rare, female predominant clinically heterogenous, autoimmune condition characterized by the presence of autoantibodies, vascular abnormalities, and fibrosis. Skin thickening as a result of fibrosis is a hallmark clinical finding, and the extent of this skin thickening further classifies clinical subsets of scleroderma. Organ systems affected may include pulmonary (interstitial lung disease, pulmonary arterial hypertension), renal (scleroderma renal crisis), gastrointestinal (dysmotility, reflux esophagitis, gastric antral vascular ectasia), cardiac (arrhythmias, cardiac fibrosis), and musculoskeletal (arthritis, contractures). Raynaud phenomenon and telangiectasis occur as a result of vascular involvement. Diagnostic workup requires a thorough history and physical examination, supplemented by autoantibody testing. No single therapeutic agent is indicated to treat all manifestations of scleroderma. Rather, system- or organ-based treatment is indicated. Not only are skin manifestations often the presenting feature of scleroderma, progressive skin changes carry prognostic implications, underscoring the value of dermatology insight for early diagnosis suspicion, referral to rheumatology, and timely management.
{"title":"Cutaneous Manifestations of Scleroderma","authors":"Manushi Aggarwal, V. Sandhu","doi":"10.1097/JDN.0000000000000725","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000725","url":null,"abstract":"ABSTRACT Scleroderma is a rare, female predominant clinically heterogenous, autoimmune condition characterized by the presence of autoantibodies, vascular abnormalities, and fibrosis. Skin thickening as a result of fibrosis is a hallmark clinical finding, and the extent of this skin thickening further classifies clinical subsets of scleroderma. Organ systems affected may include pulmonary (interstitial lung disease, pulmonary arterial hypertension), renal (scleroderma renal crisis), gastrointestinal (dysmotility, reflux esophagitis, gastric antral vascular ectasia), cardiac (arrhythmias, cardiac fibrosis), and musculoskeletal (arthritis, contractures). Raynaud phenomenon and telangiectasis occur as a result of vascular involvement. Diagnostic workup requires a thorough history and physical examination, supplemented by autoantibody testing. No single therapeutic agent is indicated to treat all manifestations of scleroderma. Rather, system- or organ-based treatment is indicated. Not only are skin manifestations often the presenting feature of scleroderma, progressive skin changes carry prognostic implications, underscoring the value of dermatology insight for early diagnosis suspicion, referral to rheumatology, and timely management.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"38 1","pages":"86 - 96"},"PeriodicalIF":0.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85460910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1097/jdn.0000000000000731
Angela L. Borger
{"title":"What Are You Bringing to the Party?","authors":"Angela L. Borger","doi":"10.1097/jdn.0000000000000731","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000731","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"23 8 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82678929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1097/JDN.0000000000000724
M. Hoedl, S. Osmancevic, S. Bauer
Objectives The aim of conducting this study was to investigate the relations between different characteristics of fecal incontinence (FI) and incontinence-associated dermatitis (IAD), placing a focus on stool consistency. Methods This is a secondary data analysis of data from cross-sectional studies. We merged data from the years 2014, 2015, and 2016. Results Of all participating persons, 1.9% were only fecal incontinent and 8.6% lost both urine and fecal material, of which 28.8% lost liquid fecal material and 71.2% lost solid stool. The prevalence of IAD among persons with FI was 5.6%. Persons with liquid FI had a 2.786-time higher risk of developing an IAD than persons with solid stool. Conclusion Because of the higher risk of developing an IAD, persons with liquid FI should be analyzed in further studies by applying the definition of FI from the International Continence Society and referring to the Bristol stool chart.
{"title":"Characteristics of Fecal Incontinence","authors":"M. Hoedl, S. Osmancevic, S. Bauer","doi":"10.1097/JDN.0000000000000724","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000724","url":null,"abstract":"Objectives The aim of conducting this study was to investigate the relations between different characteristics of fecal incontinence (FI) and incontinence-associated dermatitis (IAD), placing a focus on stool consistency. Methods This is a secondary data analysis of data from cross-sectional studies. We merged data from the years 2014, 2015, and 2016. Results Of all participating persons, 1.9% were only fecal incontinent and 8.6% lost both urine and fecal material, of which 28.8% lost liquid fecal material and 71.2% lost solid stool. The prevalence of IAD among persons with FI was 5.6%. Persons with liquid FI had a 2.786-time higher risk of developing an IAD than persons with solid stool. Conclusion Because of the higher risk of developing an IAD, persons with liquid FI should be analyzed in further studies by applying the definition of FI from the International Continence Society and referring to the Bristol stool chart.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"40 1","pages":"76 - 83"},"PeriodicalIF":0.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75139492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-26DOI: 10.1097/JDN.0000000000000730
Jason Gomez, Shehla Admani
ABSTRACT Nevus simplex, or salmon patch, is a benign vascular malformation seen in 30%–40% of infants. Most lesions are self-limiting, resolving spontaneously between the ages of 1 and 2 years. The most affected areas of the skin are the occiput and posterior neck; however, facial, scalp, and sacral involvement can also be seen. A nevus simplex must be differentiated from a port wine stain, as port wine stains are persistent and can be associated with genetic syndromes. Although sacral lesions can be common in nevus simplex complex, when associated with a second lumbosacral anomaly, further evaluation for underlying spinal dysraphism should be considered.
{"title":"Nevus Simplex","authors":"Jason Gomez, Shehla Admani","doi":"10.1097/JDN.0000000000000730","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000730","url":null,"abstract":"ABSTRACT Nevus simplex, or salmon patch, is a benign vascular malformation seen in 30%–40% of infants. Most lesions are self-limiting, resolving spontaneously between the ages of 1 and 2 years. The most affected areas of the skin are the occiput and posterior neck; however, facial, scalp, and sacral involvement can also be seen. A nevus simplex must be differentiated from a port wine stain, as port wine stains are persistent and can be associated with genetic syndromes. Although sacral lesions can be common in nevus simplex complex, when associated with a second lumbosacral anomaly, further evaluation for underlying spinal dysraphism should be considered.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"4 1","pages":"84 - 85"},"PeriodicalIF":0.4,"publicationDate":"2023-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89977706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-02DOI: 10.1097/jdn.0000000000000726
M. Reddy, Katie A. O'Connell, Megan O’Connor
{"title":"Lichen Sclerosus","authors":"M. Reddy, Katie A. O'Connell, Megan O’Connor","doi":"10.1097/jdn.0000000000000726","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000726","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"32 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85385928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/jdn.0000000000000718
Ariel Park, S. Jacob
{"title":"Papulopustular Eruptions on Inner Thighs","authors":"Ariel Park, S. Jacob","doi":"10.1097/jdn.0000000000000718","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000718","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"2 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89760277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/jdn.0000000000000723
Angela L. Borger
{"title":"JDNA Milestones","authors":"Angela L. Borger","doi":"10.1097/jdn.0000000000000723","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000723","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88306299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/JDN.0000000000000709
James M. Roush, Elizabeth A. Richards, K. Masterson, Janelle Potetz
Background Despite the known benefits, many patients deny receiving sunscreen counseling. Over the past decade, rates and treatment costs for skin cancer have risen. Purpose This study seeks to investigate provider perceptions of using sunscreen prescriptions as a method to increase patient use. Methods A descriptive online survey using a convenience sample of dermatology, internal medicine, and family medicine providers was used. Descriptive statistics summarized quantitative variables, and thematic analysis examined open-ended questions. Results Provider (N = 38 total) thoughts about sunscreen prescriptions were mixed, with many viewing sunscreen prescriptions positively (n = 15, 42.9%). Commonly listed barriers included patient lack of motivation/interest (3.53 ± 0.89), lack of standard guidelines about sunscreen counseling and prescriptions (3.34 ± 1.12), and lack of education about prescribing sunscreen (3.26 ± 1.35). Facilitators included insurance coverage (n = 21, 61.8%) and having a standardized protocol (n = 8, 23.5%). Conclusion Most providers felt prescribing sunscreen would increase patient use. Study results imply providers would utilize sunscreen prescriptions if a clear, standardized protocol was present. Education may help alleviate concerns related to insurance coverage. In consideration of time constraints, it may be beneficial for sunscreen prescriptions to be added to routine after-visit summaries and educational materials.
{"title":"The Utilization of Sunscreen Prescriptions to Increase Patient Use","authors":"James M. Roush, Elizabeth A. Richards, K. Masterson, Janelle Potetz","doi":"10.1097/JDN.0000000000000709","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000709","url":null,"abstract":"Background Despite the known benefits, many patients deny receiving sunscreen counseling. Over the past decade, rates and treatment costs for skin cancer have risen. Purpose This study seeks to investigate provider perceptions of using sunscreen prescriptions as a method to increase patient use. Methods A descriptive online survey using a convenience sample of dermatology, internal medicine, and family medicine providers was used. Descriptive statistics summarized quantitative variables, and thematic analysis examined open-ended questions. Results Provider (N = 38 total) thoughts about sunscreen prescriptions were mixed, with many viewing sunscreen prescriptions positively (n = 15, 42.9%). Commonly listed barriers included patient lack of motivation/interest (3.53 ± 0.89), lack of standard guidelines about sunscreen counseling and prescriptions (3.34 ± 1.12), and lack of education about prescribing sunscreen (3.26 ± 1.35). Facilitators included insurance coverage (n = 21, 61.8%) and having a standardized protocol (n = 8, 23.5%). Conclusion Most providers felt prescribing sunscreen would increase patient use. Study results imply providers would utilize sunscreen prescriptions if a clear, standardized protocol was present. Education may help alleviate concerns related to insurance coverage. In consideration of time constraints, it may be beneficial for sunscreen prescriptions to be added to routine after-visit summaries and educational materials.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":"2015 1","pages":"19 - 28"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73637198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：